CC BY 4.0 · Rev Bras Ginecol Obstet 2019; 41(04): 213-219
DOI: 10.1055/s-0039-1683903
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Evaluation of Immunological Parameters in Pregnant Women: Low Levels of B and NK Cells

Avaliação dos parâmetros imunológicos em mulheres gestantes: baixos níveis de células B e NK
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
2   Universidade Católica de Pernambuco, Recife, PE, Brazil
,
Thomás Virgílio Gomes
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
,
Claudeir Dias da Silva Júnior
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
,
Sandra de Andrade Heráclio
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
,
Isabela Cristina Coutinho de Albuquerque Neiva Coelho
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
,
Leuridan Cavalcante Torres
1   Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brazil
› Author Affiliations
Further Information

Publication History

06 November 2018

02 February 2019

Publication Date:
25 March 2019 (online)

Abstract

Objective To describe the immunological and hematological reference intervals of low-risk pregnant women.

Methods A cross-sectional retrospective database analysis of a basic and translational study analyzing the hematological evaluation blood counts and immunophenotyping of TCD3 + , TCD4 + , TCD8 + , B, and natural killer (NK) cells of the peripheral blood in 79 low-risk pregnant women and of 30 control women from the state of Pernambuco, Brazil, was performed.

Results No significant differences were detected between the hematological profiles of the 2nd and 3rd trimesters. Nevertheless, the median level of B cells decreased significantly in the 2nd (174 × 103 µL; p < 0.002) and 3rd trimesters (160 × 103 µL; p < 0.001), compared with the control group (296 × 103 µL). Similarly, the median level of NK cells was lower in the 2nd (134 × 103 µL; p < 0.0004) and 3rd trimesters (100 × 103 µL, p < 0.0004), compared with the control group (183 × 103 µL). In contrast, relative TCD4+ and TCD8+ levels increased in the 2nd and 3rd trimesters compared with the controls (TCD4 + : 2nd trimester = 59%; p < 0.001; 3rd trimester = 57%; p < 0.01; control = 50%; and TCD8 + : 2nd trimester = 31%; p < 0.001; 3rd trimester = 36%; p < 0.01; control = 24%).

Conclusion Low-risk pregnant women have ∼ 40% less B and NK cells in the peripheral blood, compared with non-pregnant women. These parameters may improve health assistance for mothers and contribute to define reference values for normal pregnancies.

Resumo

Objetivo Descrever o intervalo de referência imunológico e hematológico de gestantes de baixo risco.

Métodos Realizou-se uma análise retrospectiva, de um estudo básico e translacional, analisando o perfil hematológico e a imunofenotipagem das células TCD3 + , TCD4 + , TCD8 + , B e natural killer (NK) do sangue periférico de 79 gestantes de baixo risco e de 30 mulheres (controles) do estado de Pernambuco, Brasil.

Resultados Não observamos diferenças significativas entre os perfis hematológicos do 2° e 3° trimestres. No entanto, houve redução das células B no 2° (média = 174 × 103 µL; p < 0,002) e no 3° trimestres (160 × 103 µL; p < 0,001), comparado com o grupo controle (296 × 103 µL). A mediana das células NK foi menor no 2° (134 × 103 µL; p < 0,0004) e no 3° trimestres (100 × 103 µL; p < 0,0004), comparado com o grupo controle (183 × 103 µL). Porém, o percentual de TCD4+ e de TCD8+ aumentou no 2° e 3° trimestres em relação aos controles (TCD4 + : 2° trimestre = 59%; p < 0,001; 3° trimestre = 57%; p < 0,01; controle = 50%; e TCD8 + : 2° trimestre = 31%; p < 0,001; 3° trimestre = 36%; p < 0,01; controle = 24%).

Conclusão Mulheres grávidas de baixo risco têm ∼ 40% menos células B e NK no sangue periférico em comparação com mulheres não grávidas. Estes parâmetros podem melhorar a assistência à saúde das mães e contribuir para a definição de valores de referência para gestações normais.

Contributions

All of the authors contributed with the project and the interpretation of data, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published.


 
  • References

  • 1 Kumpel BM, Manoussaka MS. Placental immunology and maternal alloimmune responses. Vox Sang 2012; 102 (01) 2-12 . Doi: 10.1111/j.1423-410.2011.01533.x
  • 2 Akinbami AA, Ajibola SO, Rabiu KA. , et al. Hematological profile of normal pregnant women in Lagos, Nigeria. Int J Womens Health 2013; 5: 227-232 . Doi: 10.2147/IJWH.S42110
  • 3 Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus 2012; 28 (03) 144-146 . Doi: 10.1007/s12288-012-0175-6
  • 4 Swanepoel AC, Pretorius E. Erythrocyte-platelet interaction in uncomplicated pregnancy. Microsc Microanal 2014; 20 (06) 1848-1860 . Doi: 10.1017/S1431927614013518
  • 5 Fu B, Tian Z, Wei H. Subsets of human natural killer cells and their regulatory effects. Immunology 2014; 141 (04) 483-489 . Doi: 10.1111/imm.12224
  • 6 Song D, Shi Y. Immune system modifications and feto-maternal immune tolerance. Chin Med J (Engl) 2014; 127 (17) 3171-3180 . Doi: 10.3760/cma.j.issn.0366-6999.20133072
  • 7 Christiansen OB. Reproductive immunology. Mol Immunol 2013; 55 (01) 8-15 . Doi: 10.1016/j.molimm.2012.08.025
  • 8 Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63 (06) 425-433 . Doi: 10.1111/j.1600-0897.2010.00836.x
  • 9 Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol 2013; 69 (04) 291-303 . Doi: 10.1111/aji.12097
  • 10 Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating immune responses in pregnancy. Front Immunol 2014; 5: 196 . Doi: 10.3389/fimmu.2014.00196
  • 11 Polese B, Gridelet V, Araklioti E, Martens H, Perrier d'Hauterive S, Geenen V. The endocrine Milieu and CD4 T-lymphocyte polarization during pregnancy. Front Endocrinol (Lausanne) 2014; 5: 106 . Doi: 10.3389/fendo.2014.00106
  • 12 Köhler C, Adegnika AA, van der Linden R, Luty AJ, Kremsner PG. Phenotypic characterization of mononuclear blood cells from pregnant Gabonese and their newborns. Trop Med Int Health 2011; 16 (09) 1061-1069 . Doi: 10.1111/j.1365-3156.2011.02812.x
  • 13 Zhao Y, Dai ZP, Lv P, Gao XM. Phenotypic and functional analysis of human T lymphocytes in early second- and third-trimester fetuses. Clin Exp Immunol 2002; 129 (02) 302-308 . Doi: 10.1046/j.1365-2249.2002.01920.x
  • 14 Shields CA, McCalmon M, Ibrahim T. , et al. Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy. Am J Physiol Regul Integr Comp Physiol 2018; 315 (02) R336-R343 . Doi: 10.1152/ajpregu.00061.2018
  • 15 Gomes Fagundes DL, França EL, da Silva Fernandes RT. , et al. Changes in T-cell phenotype and cytokines profile in maternal blood, cord blood and colostrum of diabetic mothers. J Matern Fetal Neonatal Med 2016; 29 (06) 998-1004 . Doi: 10.3109/14767058.2015.1031739
  • 16 Genetu M, Damtie D, Workineh M, Mathewos Tebeje B, Enawgaw B, Deressa T. Immunological and hematological reference intervals among HIV-seronegative pregnant women in northwest Ethiopia. Int J Womens Health 2017; 9: 145-150 . Doi: 10.2147/IJWH.S126916
  • 17 Jensen F, Muzzio D, Soldati R, Fest S, Zenclussen AC. Regulatory B10 cells restore pregnancy tolerance in a mouse model. Biol Reprod 2013; 89 (04) 90 . Doi: 10.1095/biolreprod.113.110791
  • 18 Muzzio DO, Soldati R, Ehrhardt J. , et al. B cell development undergoes profound modifications and adaptations during pregnancy in mice. Biol Reprod 2014; 91 (05) 115 . Doi: 10.1095/biolreprod.114.122366
  • 19 Bhat NM, Mithal A, Bieber MM, Herzenberg LA, Teng NN. Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy. J Reprod Immunol 1995; 28 (01) 53-60 . Doi: 10.1016/0165-0378(94)00907-O
  • 20 Koopman LA, Kopcow HD, Rybalov B. , et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198 (08) 1201-1212 . Doi: 10.1084/jem.20030305
  • 21 Roussev RG, Dons'koi BV, Stamatkin C. , et al. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy. Reprod Biomed Online 2013; 26 (01) 79-87 . Doi: 10.1016/j.rbmo.2012.09.017
  • 22 Laban M, Ibrahim EA, Elsafty MS, Hassanin AS. Placenta accreta is associated with decreased decidual natural killer (dNK) cells population: a comparative pilot study. Eur J Obstet Gynecol Reprod Biol 2014; 181: 284-288 . Doi: 10.1016/j.ejogrb.2014.08.015
  • 23 Thum MY, Bhaskaran S, Abdalla HI. , et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004; 19 (10) 2395-2400 . Doi: 10.1093/humrep/deh378
  • 24 Wallace AE, Fraser R, Gurung S. , et al. Increased angiogenic factor secretion by decidual natural killer cells from pregnancies with high uterine artery resistance alters trophoblast function. Hum Reprod 2014; 29 (04) 652-660 . Doi: 10.1093/humrep/deu017
  • 25 Fu B, Li X, Sun R. , et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A 2013; 110 (03) E231-E240 . Doi: 10.1073/pnas.1206322110
  • 26 Luppi P, Haluszczak C, Trucco M, Deloia JA. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002; 47 (02) 72-81 . Doi: 10.1034/j.1600-0897.2002.1o041.x
  • 27 Kühnert M, Strohmeier R, Stegmüller M, Halberstadt E. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 76 (02) 147-151 . Doi: 10.1016/S0301-2115(97)00180-2
  • 28 Watanabe M, Iwatani Y, Kaneda T. , et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997; 37 (05) 368-377 . Doi: 10.1111/j.1600-0897.1997.tb00246.x
  • 29 Galluzzo C, Liotta G, Andreotti M. , et al. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi. J Med Virol 2012; 84 (10) 1553-1557 . Doi: 10.1002/jmv.23365
  • 30 Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol 2015; 73 (03) 199-213 . Doi: 10.1111/aji.12355
  • 31 Schettini JAC, Gomes TV, Santos Barreto AK. , et al. High levels of CXCL8 and low levels of CXCL9 and CXCL10 in women with maternal RhD alloimmunization. Front Immunol 2017; 8: 700 . Doi: 10.3389/fimmu.2017.00700